D. E. Shaw & Co., Inc. Dyne Therapeutics, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $98.6 Billion
- Q2 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 88,420 shares of DYN stock, worth $3.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88,420
Previous 50,000
76.84%
Holding current value
$3.01 Million
Previous $1.42 Million
119.87%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DYN
# of Institutions
201Shares Held
106MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$273 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$267 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$252 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$218 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$206 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.76B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...